| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Magnesium trisilicate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium hydrate |
Is a |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium carbonate mixture BPC (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aromatic magnesium carbonate mixture BP (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Compound magnesium trisilicate 250 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium trisilicate mixture BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium trisilicate powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Compound magnesium trisilicate oral powder BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium carbonate compound tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium carbonate compound powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium hydroxide [laxative] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium sulfate powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium hydroxide mixture BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely magnesium hydroxide 83 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magaldrate (substance) |
Is a |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium-based antacid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium hydroxide (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium oxide (substance) |
Is a |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium carbonate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium trisilicate+belladonna 0.15mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing belladonna and magnesium trisilicate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Liquid paraffin+magnesium hydroxide oral emulsion BP (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing aluminium hydroxide and magnesium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing alginic acid and aluminium hydroxide and magnesium trisilicate and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing aluminium hydroxide and magnesium hydroxide and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing magnesium malate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely magnesium malate 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium trisilicate (substance) |
Is a |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Calcium carbonate + famotidine + magensium hydroxide (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing aluminium hydroxide and magnesium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Citric acid- and magnesium carbonate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing magnesium hydroxide and mineral oil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing magnesium carbonate and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing activated charcoal and magnesium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing calcium carbonate and magnesium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Aluminium oxide- and magnesium hydroxide- and oxetacaine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing magnesium hydroxide and omeprazole and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium hydroxide 700 mg and omeprazole 20 mg and sodium bicarbonate 600 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely magnesium hydroxide 700 milligram and omeprazole 40 milligram and sodium bicarbonate 600 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium hydroxide |
Is a |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Magnesium alginate (substance) |
Is a |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Almagate (substance) |
Is a |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Almasilate |
Is a |
False |
Magnesium-based antacid |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]